Related Experiment Video
Updated: May 10, 2026
04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
Spinal cord stimulation for chronic limb ischemia.
Joseph J Naoum1, Elias J Arbid
1The Methodist Hospital, Houston, Texas, USA.
Methodist Debakey Cardiovascular Journal
|June 28, 2013
Summary
Spinal cord stimulation (SCS) offers a novel treatment for chronic limb ischemia when traditional methods fail. This therapy improves pain, healing, and limb salvage by modulating blood flow and nerve signals.
Area of Science:
- Vascular Surgery
- Neuromodulation
- Regenerative Medicine
Background:
- Chronic limb ischemia (CLI) poses challenges for patients unsuitable for conventional endovascular or surgical revascularization.
- Persistent ischemia and pain in CLI can lead to significant morbidity and potential limb loss.
Purpose of the Study:
- To evaluate the efficacy of spinal cord stimulation (SCS) as an alternative treatment for CLI.
- To explore the mechanisms by which SCS improves microcirculation and alleviates ischemic symptoms.
Main Methods:
- Spinal cord stimulation (SCS) involves implanting electrodes in the epidural space to stimulate sensory fibers.
- SCS modulates the release of vasodilatory molecules, reduces vascular resistance, and inhibits sympathetic vasoconstriction.
- Patient selection for SCS therapy is guided by microcirculatory parameters.
Main Results:
- SCS therapy demonstrated significant improvements in pain relief for CLI patients.
- The treatment effectively halted the progression of ischemic ulcers.
- Limb salvage was potentially achieved in patients treated with SCS.
Conclusions:
- Spinal cord stimulation (SCS) is a viable therapeutic option for select CLI patients.
- SCS offers a mechanism to improve distal blood flow and manage ischemic pain.
- Optimizing patient selection based on microcirculatory data enhances SCS treatment outcomes for CLI.
